Enveric Biosciences ENVB
NASDAQ ENVB
$1.43 -0.03 (-2.13%)
As of: Sep 30, 2026 · 10:22 AM EDT

Enveric Biosciences (ENVB) Accounts Payables (2010 - 2026)

Updated

Enveric Biosciences' Accounts Payables came in at $682,794 for Q2 2026, down 34.4% from $1.04 million a year earlier but up 143.6% from the prior quarter.

Analysis

Enveric Biosciences (ENVB) Accounts Payables (2010 - 2026) Analysis & Trends

At the end of FY2025, Enveric Biosciences' Accounts Payables was $581,020, down 21.0% from FY2024.

  • Accounts Payables carries a five-year compound annual growth rate of -3.1% (FY2020 to FY2025).
  • Going back by year, Accounts Payables was $735,098 in FY2024 (-39.7%), $1.22 million in FY2023 (+163.1%), $463,275 in FY2022 (-32.2%) and $683,393 in FY2021 (+0.3%).
  • The five-year range for quarterly Accounts Payables is $280,315 (Q1 2026) to $2.16 million (Q3 2021).
  • Year-over-year, Accounts Payables has declined for three consecutive quarters, with an average decline of 14.9% over the last eight quarters.
  • The fastest year-over-year change in Accounts Payables over five years came in Q4 2023 (growth of 163.1%), and the weakest in Q3 2022 (a decline of 67.2%).
  • Business Quant data shows ENVB's Accounts Payables at $280,315 (Q1 2026), $581,020 (Q4 2025) and $683,707 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 9.22 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 33.30 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -22.89 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 674.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 429.50 Mn
10 Enveric Biosciences 5.86 Mn -15.78 Mn - 682,794.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 682,794.00
Mar 31, 2026 280,315.00
Dec 31, 2025 581,020.00
Sep 30, 2025 683,707.00
Jun 30, 2025 1.04 Mn
Mar 31, 2025 669,194.00
Dec 31, 2024 735,098.00
Sep 30, 2024 576,324.00
Jun 30, 2024 459,898.00
Mar 31, 2024 1.85 Mn
Dec 31, 2023 1.22 Mn
Sep 30, 2023 1.10 Mn
Jun 30, 2023 1.23 Mn
Mar 31, 2023 1.79 Mn
Dec 31, 2022 463,275.00
Sep 30, 2022 710,314.00
Jun 30, 2022 754,296.00
Mar 31, 2022 1.22 Mn
Dec 31, 2021 683,393.00
Sep 30, 2021 2.16 Mn
API Access

Enveric Biosciences Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=ENVB&period=max&api_key=YOUR_API_KEY